Resorbable Vascular Scaffolds Market Report 2026

Resorbable Vascular Scaffolds Market Overview

• Resorbable Vascular Scaffolds market size has reached to $0.51 billion in 2025 • Expected to grow to $0.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases Boosts Advanced Treatment Solutions • Market Trend: Advancements In Magnesium Scaffolds For Enhanced Cardiovascular Treatments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Resorbable Vascular Scaffolds Market?

Resorbable vascular scaffolds are medical devices used to treat vascular diseases by providing temporary structural support to blood vessels. Resorbable vascular scaffolds gradually dissolve after fulfilling their purpose, reducing the risks associated with permanent implants. By promoting natural vessel healing and restoring normal blood flow, they offer a safer and more effective alternative to traditional stents. The main product designs in the resorbable vascular scaffolds are multilumen and single lumen. Multilumen resorbable vascular scaffolds refer to advanced bioresorbable devices with multiple channels or lumens designed to provide enhanced support, facilitate blood flow, and promote natural vessel healing in complex vascular conditions. The materials used include poly-glycolic acid, poly-l-lactic acid, and poly-l-lactic-co-glycolic acid, along with deployment techniques such as balloon-expandable and self-expandable. These scaffolds are applied in treating coronary artery disease, peripheral vascular disease, and pulmonary artery disease, serving end users such as ambulatory surgical centers, hospitals, and specialty clinics.

What Is The Resorbable Vascular Scaffolds Market Growth Forecast?

The resorbable vascular scaffolds market size is expected to see rapid growth in the next few years. It will grow to $0.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for safer alternatives to permanent stents, rising investments in cardiovascular device innovation, expansion of bioresorbable material research, growing focus on patient-specific treatment solutions, increasing regulatory support for advanced vascular devices. Major trends in the forecast period include increasing development of bioabsorbable scaffold materials, rising adoption of next-generation vascular implants, growing focus on temporary vessel support technologies, expansion of clinical trials for resorbable devices, enhanced emphasis on long-term patient outcomes.

Global Resorbable Vascular Scaffolds Market Segmentation

1) By Product Design: Multilumen, Single Lumen 2) By Material Type: Poly-Glycolic Acid, Poly-L-Lactic Acid, Poly-L-Lactic-Co-Glycolic Acid 3) By Deployment Technique: Balloon-Expandable, Self-Expandable 4) By Application: Coronary Artery Disease, Peripheral Vascular Disease, Pulmonary Artery Disease 5) By End User: Ambulatory Surgical Centers, Hospitals, Specialty Clinics Subsegments: 1) By Multilumen: Helical Design, Braided Design, Other Multilumen Designs 2) By Single Lumen: Straight Tube Design, Corrugated Tube Design, Other Single Lumen Designs

What Is The Driver Of The Resorbable Vascular Scaffolds Market?

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the resorbable vascular scaffolds market going forward. Cardiovascular diseases are driven by factors such as poor lifestyle choices, aging, high blood pressure, high cholesterol, diabetes, smoking, and genetic predispositions. Resorbable vascular scaffolds are revolutionizing the treatment of cardiovascular diseases by providing temporary structural support to restore blood flow while gradually dissolving, reducing long-term complications associated with permanent implants and promoting natural vessel healing and functionality. For instance, in June 2024, according to the data published by the American Heart Association, Inc., a US-based non-profit organization, more than 150 million people in the U.S. will have a poor diet by 2050, contributing to a nearly 40% increase in adult obesity (from 43.6% to 60.6%) and over 60% in children (from 20.6% to 33%), while 61% of adults are projected to have cardiovascular disease, with the highest obesity growth among adults aged 20-64. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the resorbable vascular scaffolds industry.

Key Players In The Global Resorbable Vascular Scaffolds Market

Major companies operating in the resorbable vascular scaffolds market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik, Lepu Medical Technology, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., ICON Interventional Systems, MicroPort Scientific Corporation, Cook Medical, Cardinal Health Interventional Division, Medinol Ltd., Alvimedica, OrbusNeich Medical

Global Resorbable Vascular Scaffolds Market Trends and Insights

Major companies operating in the resorbable vascular scaffolds market are developing magnesium scaffolds to improve biocompatibility and provide better mechanical support. Magnesium scaffolds promote natural vessel healing while reducing inflammation and complications associated with traditional polymer-based scaffolds. For instance, in March 2024, Biotronik, a Germany-based medical device company, received food and drug administration (FDA) breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). The Freesolve RMS is a breakthrough device designed for individuals with chronic limb-threatening ischemia (CLTI), offering an advanced treatment option for below-the-knee (BTK) interventions. It features BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology, which enhances safety, deliverability, and vessel support. The scaffold provides short-term support to resist vessel recoil during healing.

What Are Latest Mergers And Acquisitions In The Resorbable Vascular Scaffolds Market?

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems Inc. for an undisclosed amount. With this acquisition, Abbott will expand its vascular portfolio, improve treatment options, and enhance its ability to care for patients suffering from peripheral and coronary artery disease. Cardiovascular Systems Inc. (CSI) is a US-based medical device company specializing in developing innovative atherectomy systems used to treat peripheral and coronary artery diseases.

Regional Outlook

North America was the largest region in the resorbable vascular scaffolds market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Resorbable Vascular Scaffolds Market?

The resorbable vascular scaffolds market consists of sales of resorbable scaffold systems, resorbable scaffold delivery devices, and bioresorbable stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Resorbable Vascular Scaffolds Market Report 2026?

The resorbable vascular scaffolds market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the resorbable vascular scaffolds industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.